Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
86 hedge funds and large institutions have $677M invested in Loxo Oncology, Inc in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 7 closing their positions.
214% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 7
118% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 17
25% more capital invested
Capital invested by funds: $543M → $677M (+$133M)
19% more funds holding
Funds holding: 72 → 86 (+14)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.09M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.04M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.45M |
| 4 |
PC
Paulson & Co
New York
|
+$2.35M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$33.8M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$6.86M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$3.31M |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$1.77M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$688K |
LOXO Hedge Fund Activity: Q4 2016 in Review
86 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q4 2016, worth a combined $677M — up 25% from $543M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new LOXO positions and 7 closed out — a net gain of 15 holders — while 37 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $9.09M. The largest seller was NEA Management Company, exiting entirely with an estimated $33.8M sold.
- 86 institutional investors held Loxo Oncology, Inc (LOXO) as of Q4 2016, up from 72 in Q3 2016.
- Funds reported $677M of Loxo Oncology, Inc stock for Q4 2016, up 25% quarter-over-quarter.
- 22 funds opened new Loxo Oncology, Inc positions in Q4 2016 and 7 closed out, a net change of +15 holders.
- The largest Loxo Oncology, Inc buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $9.09M added.
- The largest Loxo Oncology, Inc seller in Q4 2016 was NEA Management Company, an estimated $33.8M sold.
Based on aggregated 13F filings for Q4 2016.